Improvement effect of synbiotics intake on stool frequency in constipation-prone healthy participants: placebo-controlled, randomised, double-blind, parallel-group comparison
Beneficial Microbes · 20.08.2026 · 1-15
DOI: 10.1163/18762891-bja00134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beneficial Microbes, erschienen am 20.08.2026. Verfasst von T Shima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, Japan. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Synbiotics exert various physiological effects by complementing the physiological functions of both probiotics and prebiotics. Chronic constipation is a prevalent global health concern, and despite several clinical studies utilising synbiotics, definitive conclusions regarding its efficacy remain elusive. This study aimed to investigate the effect of a synbiotic combination of Lacticaseibacillus paracasei strain Shirota (LcS: formerly known as Lactobacillus casei strain Shirota) and galactooligosaccharides (GOS), both of which independently improve defecation symptoms, on defecation frequency in constipation-prone healthy Japanese adults. This study employed a placebo-controlled, randomised, double-blind, parallel-group comparison design over a 4-week consecutive intake period. The primary objective was to evaluate the efficacy of the synbiotic intervention on bowel movement frequency in healthy adults prone to constipation. The synbiotic group exhibited a significantly increased defecation frequency at week 2 ( ) but not at week 4, whereas the number of defecation days showed only a trend at week 2 ( ). This represents a key limitation of this study. A significant positive correlation was observed between faecal LcS counts and defecation parameters in the synbiotic group, with no equivalent correlation observed for endogenous Lactobacillaceae in either group. This suggests a strain-specific effect of LcS beyond a general class effect of Lactobacillaceae . Additionally, increases in faecal Bifidobacterium counts and a decrease in isobutyric and isovaleric acid levels were observed along with improvements in defecation-related symptoms. These findings suggest that the combination of LcS and GOS may contribute to improvements in constipation-related outcomes in healthy individuals prone to constipation. The study was registered by the University Hospital Medical Information Network: registration number: UMIN000039236.
Autor:innen und Institutionen
- Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, Japan.
Zitieren
APA
Shima, T., Kaga, C., Kado, Y., Date, R., Shimamoto, K., Tajima, S., Makino, H., Shimizu, K., Katto, M., Kato, A., Tsuji, H., & Matsumoto, S. (2026). Improvement effect of synbiotics intake on stool frequency in constipation-prone healthy participants: placebo-controlled, randomised, double-blind, parallel-group comparison. Beneficial Microbes, 1-15. https://doi.org/10.1163/18762891-bja00134
Vancouver
Shima T, Kaga C, Kado Y, Date R, Shimamoto K, Tajima S, et al. Improvement effect of synbiotics intake on stool frequency in constipation-prone healthy participants: placebo-controlled, randomised, double-blind, parallel-group comparison. Beneficial Microbes. 2026:1-15. doi:10.1163/18762891-bja00134
BibTeX
@article{Shima2026,
author = {Shima, T and Kaga, C and Kado, Y and Date, R and Shimamoto, K and Tajima, S and Makino, H and Shimizu, K and Katto, M and Kato, A and Tsuji, H and Matsumoto, S},
title = {Improvement effect of synbiotics intake on stool frequency in constipation-prone healthy participants: placebo-controlled, randomised, double-blind, parallel-group comparison},
journal = {Beneficial Microbes},
year = {2026},
pages = {1--15},
doi = {10.1163/18762891-bja00134}
}
EUVIMED